News
10-13-2010, 11:40 PM
Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it issued a letter to its shareholders advising that it had filed for patent protection worldwide and expects to enter Phase I clinical trials for its principal drug, Adva-27a, beginning with GMP manufacturing and animal tox studies.
More... (http://www.news-medical.net/news/20101014/Sunshine-Biopharma-to-enter-Adva-27a-Phase-I-clinical-trial-for-Multi-Drug-Resistant-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20101014/Sunshine-Biopharma-to-enter-Adva-27a-Phase-I-clinical-trial-for-Multi-Drug-Resistant-breast-cancer.aspx)